WHO reclassifies combined birth control pills as carcinogen; risk context explained

A classification labels combined oral contraceptives as a carcinogen, but the analytical nuance is that this indicates a potential increased risk of breast and cervical cancers, not a deterministic outcome. The move likely stems from updated IARC/WHO evidence reviews, though the specific agency and basis are not stated. This matters because it could shift public health messaging and prescribing practices, though absolute risk remains low for most users.